Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzylox

Details Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzylox Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzylox

1998-12-31

2000-10-24

Kishore, Gollamudi S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

514353, 546244, A61F 606, A01N 4340, A61K 3144, C07D21156, C07D21198

Patent

active

061363359

ABSTRACT:
Novel phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity as well as anti-viral activity. These novel compounds can be incorporated within contraceptive compositions to provide for spermicidal or sperm-immobilizing activity.

REFERENCES:
patent: 5593993 (1997-01-01), Morin, Jr. et al.
patent: 5658907 (1997-08-01), Morin, Jr. et al.
patent: 5686428 (1997-11-01), Eriksson et al.
patent: 5714503 (1998-02-01), Morin, Jr. et al.
patent: 5786462 (1998-07-01), Schneider et al.
Ahgren, C. et al., 1995, Antimicrob. Agents Chemotherapy, 39, 1329-1335 The PETT Series, a New Class of Potent Nonnucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
Baba, M., et al., 1992, Antiviral Res., 17, 245-264 Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives.
Balzarini, J. et al., 1992, Proc. Natl. Acad. Sci. U S A, 89, 4392-4396 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'spiro-5"-(4"-amino-1",2"-oxathiole -2",2"-dioxide)pyrimidine (TSAO) nucleoside analogues: Hightly selective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
Bartlett, P.A. et al., 1989, Molecular Recognition in Chemical and Biological Problems, Special Pub., Royal Chem. Soc., 78, 182-196 Caveat: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules.
Bell, F. W., et al., 1995, J. Med. Chem., 38, 4929-4936 Penethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Syntheis and Basic Structure-Activity Relationship Studies of PETT Analogs.
Blaney, J.M. and Dixon, J.S., 1993, Perspectives in Drug Discovery and Design, 1, 301 A good ligand is hard to find: Automated docking methods.
Bohm, H. J., 1992, J. Comput. Aided. Mol. Des., 6, 593-606 LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.
Bohm, H.J., 1992, J. Comp. Aid. Molec. Design, 6, 61-78 The computer program LUDI: A new mehtod for the de novo design of enzyme inhibitors.
Bohm, H. J., J. Comput. Aided. Mol. Des., 1994, 8, 243-256; 1996 The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of konwn three-dimensional structure.
Bosworth, N., et al., 1989, Nature, 341: 167-168 Scintillation proximity assay.
Brooks, B.R. et al., 1983, J. Comp. Chem., 4, 187-217 CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations.
Burkert, U. and Allinger, N.L., 1982, Molecular Mechanics, ACS Monograph, 177, 59-78, American Chemical Society, D.C. Methods for the Computation of Molecular Geometry.
Cantrell, A. S., et al., 1996, J. Med. Chem., 39, 4261-4274 Phenethylthiazolylthiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure-Activity Relationship Studies of PETT Analogs.
Chemical substance index page, Chemical Abstracts, 13th Collective Chemical Substance Index, Book 52, p. 1272 (1992-1996).
Connolly, M. L., 1983, Science, 221, 709-713 Solvent-Accessible Surfaces of Proteins and Nucleic Acids.
D'Cruz, et al., 1996, Biol. Reprod., vol. 54, pp. 1217-1228 Recombinant Soluble Human Complement Receptor Type 1 Inhibits Antisperm Antibody-and Neutrophil-Mediated Injury to Human Sperm.
D'Cruz, et al., 1998, Biol. Reprod., vol. 58, pp. 1515-1526 Spermicidal Activity of Metallocene Complexes Containing Vanadium (IV) in Humans.
Danel, K. et al., 1997, Acta Chemica Scandinavica, 51, 426-430 Anti-HIV Active Napthyl Analogues of HEPT and DABO.
Danel, K. et al., 1998, J. Med. Chem., 41, 191-198 Synthesis and Anti-HIV-1 Activity of Novel 2,3-Dihydro-7H-thiazolo[3,2-.alpha.]pyrimidin-7-ones.
Danel, K., et al., 1996, J. Med. Chem., 39, 2427-2431 Synthesis and Potent Anti-HIV-1 Activity of Novel 6-Benzyluracil Analogues of 1-[2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Das, K. et al., 1996, J. Mol. Biol., 264, 1085-1100 Crystal Structures of 8-C1 and 9-C1 TIBO Complexed with Wild-type HIV-1 RT and 8-C1 TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant.
Davies et al., 1976, J. Chem. Society, Perkin Translations 1, vol. 2, pp. 138-14 Condensed Thiophen Ring Systems. Part XIX. Synthesis of 6, 7-Dihydrothieno [3,2-c] pyridines by Intramolecular Cyclistion of 2-(2- or 3-Thienyl)ethyl Isothiocyanate.
De Clercq, E., 1992, J. Acquired Immune Defic. Syndr. Res. Human. Retrovirus, 8, 119-134 HIV Inhibitors Targeted at the Reverse Transcriptase.
Ding, J., 1995, et al., Nat. Struct. Biol., 2, 407-415 Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors.
Erice, A. et al., 1993, Antimicrob. Ag. Chemother., 37, 835 Anti-Human Immunodeficiency Virus Type 1 Activity of an Anti-CD4 Immunoconjugate Containing Pokeweed Antiviral Protein.
Gittos et al., J. Chem. Society, Perkin 1, pp. 169-143 A New Synthesis of Isocyanates.
Goodsell, D.S. and Olson, A.J., 1990, Proteins: Struct. Funct. Genet., 8, 195-202 The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection.
Greene, W.C., 1991, New England Journal of Medicine, 324, 308-317 Automated Docking of Substrates to Proteins by Simulated Annealing.
Hira, et al., 1997, Int. J. STD AIDS, vol. 8, pp. 243-250 Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
Hopkins, A. L. et al., 1996, J. Med. Chem., 39, 1589-1600 Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformation Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors.
Jones, T. A. et al., 1991, Acta Crystallogr. A., 47, 110-119 Improved Methods for Building Protein Models in Electron Denisty Maps and the Location of Errors in these Models.
Kohlstaedt, L. A. et al., 1992, Science, 256, 1783-1790 Crystal Structure at 3.5 .ANG. Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor.
Kuntz, I.D., et al., 1995, J. Mol. Biol., 1982, 161, 269-288 A Geometric Approach to Macromolecule-Ligand Interactions.
Larder et al., 1993, Nature, 365, 451-453 Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
Luty, B. A. et al., 1995, J. Comp. Chem., 16, 454-464 A Molecular Mechanics/Grid Methods for Evaluation of Ligand-Receptor Interactions.
Mai, A. et al., 1997, J. Med. Chem., 40, 1447-1454 Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: Novel Non-Nucleoside Reverse Transcriptase Indhibitors of the S-DABO Series.
Marshall, G.R., 1987, Ann. Ref. Pharmacol. Toxicol., 27, 193 Computer-Aided Drug Design.
Martin, Y.C., 1992, J. Med. Chem., 35, 2145-2154 3D Database Searching in Drug Design.
Mao, C. et al., 1998 Bioorganic & Medicinal Chemistry Letters 8, pp. 2213-2218 Structure-Based Design of N-[2-(1-Piperidinylethyl)]-N'-[2-(5-Bromopyridyl)]-Thiourea and N-[2-(1-Piperazinylethyl)-N'-[2-(5-Bromopyridyl)]-Thiourea as Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase.
Mitsuya, H. et al., 1990, Science, 249, 1533-1544 Molecular Targets for AIDS Therapy.
Nishibata, Y. and Itai, A., 1991, Tetrahedron, 47, 8985 Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation.
Pauwels, R. et al., 1990, Nature, 343, 470-474 Potent and selective inhibitionof HIV-1 replication in vitro by a novel series of TIBO derivatives.
Pontikis, R. et al., 1997, J. Med. Chem., 40, 1845-1854 Synthesis and Anti-HIV Activity of Novel N-1 Side Chain-Modified Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Remington's Pharmaceutical Sciences, Chapter 43, 14th Ed., Mack Publishing Col, Easton PA 18042, USA Topical Drugs.
Ren, J. et al., 1995, Structure, 3, 915-926 The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design.
Roddy, et al., 1998, N. Eng. J. Med., vol. 339, pp. 504-510 A Controlled Trial of Nonoxynol 9 Film to Reduce Male-To-Female Transmission of Sexually Transmitted Diseases.
Romero, D. L. et al., 1993, J. Med. Chem., 36, 1505-1508 Bis(heteroary

Affiliated with

Also associated with

Rating

Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzylox does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzylox, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzylox will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1960708